One of the most predominantly found cancer types in both men and women, small cell lung cancer, and non-small cell lung cancer treatments have advanced substantially. With an advanced treatment procedure, there has been a considerable decrease in death rates. That being said, of course, the lower smoking rates have also been a significant cause, which has led to a lot lesser people being diagnosed with lung cancer.
Various treatments of various types of lung cancer Both small cell and non-small cell lung cancers have different approaches to treatment. In this respect, mention may be made of immunotherapy and targeted therapy that is quite effective in dealing with NSCLC. Both immunotherapy and targeted therapy drugs are also referred to as precision medicine because they typically target the cancer cells with a specific gene mutation. Effectiveness of newer treatment methods Relevant information has been obtained from the NCI’s Surveillance SEER data by researchers to stand by the claim that there has been a decline in the death rates of lung cancer. The inference is in affirmative, i.e., it claims that there has been a steady downfall in the death rates than a rise in the rate of new cases at present, due to the newer treatments. For instance, the death rates in men have gone down by 6.3% in between 2013-2016. Similarly, there has been a decline in death rates in patients who have been diagnosed with small-cell lung cancer. However, a different factor may be taken into account her. Data claims that the decline in death rates due to treatment advances isn’t as much as the diagnosis of new cases due to lesser smoking rates. In fact, researchers have also acknowledged that tobacco consumption has reduced in both men and women. Conclusion So far, it has been a breakthrough that the most common cancer category, non-small cell lung cancer mortality rates, has gone down due to the newer forms of treatments. The declination proves it is ongoing and shows promising numbers. The contribution of several targeted therapies approved in recent years is immense. That being said, doctors have also acknowledged that treating both non-small cell lung cancer and small cell lung cancer is exceptionally tough, despite the advanced medical facilities, especially if it has been diagnosed in the advanced stages. While it is true that not all lung cancers have smoking as an integral cause, it certainly has a significant part to play in it. Therefore, quitting smoking is the first step towards reducing the risk of having cancer. Read:- How low dose of erlotinib is helpful for weak or elderly patients with non small cell lung cancer.
0 Comments
Leave a Reply. |
AuthorMy Name is Amit Sharma I am a pharmacist, I am having 25+ years of experience in Pharma medications. ArchivesCategories
All
|